Frank Curzio
By Frank CurzioMay 2, 2016

Ep 408: Frankly Speaking: Immunotherapy, Robotics, and Portfolio Diversity

Welcome back to another episode of Frankly Speaking.

We start today with some feedback from Robin about immunotherapy.

The next is a question from Darren who has a question about portfolio diversity.

[app_audio src=”http://traffic.libsyn.com/sainvestorradio/Frankly20Speaking20EP20411.mp3″]

Next, Julian writes in asking about auto loans and especially Miller Industries, Inc. (MLR).

And our last question comes from Josh – Is Apple a buy now?

As always, thanks for listening and good investing!

Read the signs. Beat the market.
The market intelligence you need to invest one step ahead. Go beyond the headlines. Invest with an insider’s edge.
More about Podcast

Should you buy Cerebras on this pullback?

Cerebras (CBRS) is sinking after its earnings miss—is it a buying opportunity? Plus, here's what's really driving Trump's sudden shift on Iran… 2 stocks for your humanoid robot watchlist… And politicians need to change the data center narrative.

Stop believing this lie about the U.S. dollar

Think the U.S. dollar isn't backed by anything? Think again. Plus, inflation is still hot—will the Fed do anything about it? … CoreWeave (CRWV) and Super Micro (SMCI) earnings… Nvidia’s (NVDA) $500B announcement… And the gold rally.

Is SpaceX a buy on its pullback?

Should you buy SpaceX (SPCX) as shares pull back? Plus, a volatile earnings pattern… Hyperscaler capex is paying off… Disney (DIS) is uninvestable… Why is AMD (AMD) down on solid earnings? … And a political headwind for data centers.

More from Frank Curzio
Artificial intelligence

Are smarter AI models creating a cyber threat?

OpenAI's HuggingFace debacle: Is AI a cybersecurity risk? Plus, SuperMicro's (SMCI) margins… Open-source vs. closed-source AI models… 2 no-brainer AI power winners… The sector with the most AI risk… China's market manipulation… And stay cautious on SpaceX (SPCX).

Is IBM a buy after its worst day in decades?

IBM's (IBM) worst day in 58 years—is it a buying opportunity? Plus, Fed Chair Warsh's testimony… The odds of a rate hike dropped significantly… Two AI buys… The perfect backdrop for big banks… And Wrap's (WRAP) growing TAM.

How much longer can this bull market last?

Meb Faber, cofounder and chief investment officer of Cambria Investment Management, breaks down his new book on the rise of the 250-year bull market… and how much longer it can last. Plus, why U.S. investors should look abroad.